Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Auxly Cannabis Group Inc T.XLY

Alternate Symbol(s):  CBWTF

Auxly Cannabis Group Inc. is a Canada-based consumer packaged goods company in the cannabis products market. The Company is focused on developing, manufacturing and distributing branded cannabis products. Its brands include Parcel, Back Forty, Foray, Dosecann and Kolab Project. It provides various products, including vaporizers, edibles, dried flowers, pre-rolls, capsules and oils and concentrates. The Company also conducts wholesale bulk sales of dried cannabis to various licensed producers in Canada. Its subsidiaries include Auxly Charlottetown Inc., Auxly Ottawa Inc., and Auxly Leamington Inc. The Company’s primary Cannabis 2.0 Product development, manufacturing and R&D activities are conducted by its subsidiary Auxly Charlottetown Inc. at a cannabis processing facility located in Charlottetown, Prince Edward Island. Auxly Ottawa Inc. holds licenses for cultivation and processing and conducts the Company’s primary dried flower and pre-roll manufacturing.


TSX:XLY - Post by User

Bullboard Posts
Comment by archdiamondon Feb 23, 2018 11:58pm
189 Views
Post# 27613550

RE:Delay

RE:DelayMore money in medical cannabis, and a major shortage over in Europe. I believe the delay will put all the major companies focused on export markets. If they continue to be more lucrative than when we are legal in our country, the shortage will be here in this country. Especially since most of that world lives on supply contracts. 

This one link reports Germany pharmacies are charging 125 Euros for 5 grams. That's $39.00 a gram Canadian. Looks like there is a lot more profit exporting overseas. Glad ABCN is our partner as they are one of the few companies with a Health Canada export license, including oils as well. We can send all our trim and trash from the greenhouses to them for making oils for export.






DSEEGS wrote:

-


Canada has delayed the legalization process for recreational cannabis-use. It was supposed to be legalized by July of this year, but now that’s not going to happen. As a result, we have seen a number of cannabis stocks start to plunge. It’s a shame, a lot of people were eager to know the direction the Canadian cannabis industry was going to head in this year.

That said, I don’t think every Canadian cannabis company is going to struggle because of the delay. In fact, there’s one company in particular that just might end up benefiting from it. Who? Why the first royalty marijuana stock, of course!

Cannabis Wheaton Income Corp. (CVE:CBW)

A delay might look like it would pose a threat to Cannabis Wheaton, but I actually think it might end up being the opposite. Headquartered in Toronto, Cannabis Wheaton is an investment company that primarily looks to provide investor returns via capital appreciation in the cannabis sector in Canada.

>>Two Canadian Cannabis Stocks Inching Higher

It currently has a market capitalization of 592.64 million. The company itself has had a positive past couple of months, witnessing some massive gains in its stock price as well as announcing a new joint venture with one of the largest greenhouse builders in Canada: Peter Quiring.

So, why might Cannabis Wheaton benefit from the delay? Well, it all boils down to the simple fact that Cannabis Wheaton mostly works with small or private operations. Essentially, the delay will give these small operations, which tend to be reasonably low-key, more time to work out any issues they have been having, such as production issues. It will also give them more time to give Cannabis Wheaton their licensed quota.

Not everyone will agree with this, however. In fact, the stock is actually trading down nearly 3% today. Still, I think giving these companies more time to work with Cannabis Wheaton will prove to be beneficial in the long run. Sometimes, it’s best not to rush things.



very true.....

 


Bullboard Posts